October 16, 2021 23:24 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Rahul Dravid set to become Team India coach after T20 World Cup: Reports | Sonia Gandhi slams govt over J&K civilian killings, questions silence on China | I am a full time, hands-on Congress president: Sonia Gandhi | Puducherry extends anti-COVID-19 restrictions till Oct 31 | India records 15,981 new COVID-19 cases in past 24 hours
Bharat Biotech's Covaxin recommended for use in children below 18 years Covaxin | COVID-19 vaccine
Image tweeted by @IndianEmbasyTR

Bharat Biotech's Covaxin recommended for use in children below 18 years

India Blooms News Service | @indiablooms | 12 Oct 2021, 09:53 pm

New Delhi/IBNS: An expert panel on Tuesday recommended Bharat Biotech's Covaxin to be administered on children between the ages of two and 18.

"Bharat Biotech has submitted data from clinical trials in the two - 18 age group for Covaxin to CDSCO (Central Drugs Standard Control Organisation). The data has been thoroughly reviewed by the Subject Expert Committee (SEC)... provided positive recommendations," the Hyderabad-based company said.

"This represents one of the first approvals worldwide for COVID-19 vaccines for the two - 18 age group... We now await further regulatory approvals prior to product launch and market availability of Covaxin for Children," the company said.

That final approval, which is more like a formality, will be given by the Drug Controller General of India.

Covaxin will be only the second vaccine against COVID-19 to be cleared for use on kids in India.

In August, Zydus Cadila's three-dose DNA jab was allowed to be used on adults and children over 12.